A Pilot Study On Identification And Management Of Drug Induced Sexual Dysfunction: A Collaborative Approach By Clinical Pharmacist And Psychiatrist

Objective: To assess the role of clinical pharmacists in the identification and management of drug-induced sexual dysfunction in collaboration with the psychiatrist and also to determine the prevalence and pattern of drug-induced sexual dysfunction, identify nature and extend of drug-induced sexual dysfunction, and assess the pattern of management of drug-induced sexual dysfunction. Methods: This periodic prevalence interventional study was carried out among patients who visited the psychiatric department of a university hospital over three month’s period. Patients were screened for sexual dysfunction using the Arizona Sexual Experience Scale (ASEX) by study pharmacists. Results: Of the 100 patients reviewed, only 50% of subjects met the study criteria. Depression (42%) was the most common clinical diagnosis among the study patients. The overall prevalence of drug-induced sexual dysfunction was 16%. A higher incidence of drug-induced sexual dysfunction was observed in men (62.5%). Decrease libido (40%) was the most prominently observed drug-induced sexual dysfunction in both genders. Antidepressant (50%) was the most common class of drugs implicated in sexual dysfunction. Drug-induced sexual dysfunction was pharmacologically managed with vaginal lubrication (40%), Tadalafil (20%) and Tadalafil+Dapoxetine combination (40%). Conclusion: With this study, provided a vision, further how prospective studies in this arena may be carried out for better understanding drug-induced sexual dysfunction and how a clinical pharmacist can contribute for better health care of patients in the sex clinic by collaborating with medical practitioners.

Keywords

Sexual dysfunction, Drug-induced sexual dysfunction, Prevalence, Clinical Pharmacist’s Role, Sex clinic

Citation

Shakya B., Babu T., Shafi P. M., Tejasri V., Sebastian J., Manohar J. S., Lucca J. M.. A Pilot Study On Identification And Management Of Drug Induced Sexual Dysfunction: A Collaborative Approach By Clinical Pharmacist And Psychiatrist. International Journal of Pharmacy and Pharmaceutical Sciences. 2020 Feb; 12(2): 32-37

URI

https://imsear.searo.who.int/handle/123456789/206039

Collections

International Journal of Pharmacy and Pharmaceutical Sciences

Full item page